Combihale FF 250 Redicaps 30's

Combihale FF 250 Redicaps is used to treat and prevent asthma and chronic obstructive pulmonary disease (COPD) symptoms. Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell and produce extra mucus, leading to difficulty breathing. COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes).

Combihale FF 250 Redicaps contains Formoterol fumarate, a bronchodilator that relaxes airway muscles to improve airflow, and Fluticasone propionate, a corticosteroid that reduces inflammation in the airways. Together, they help ease breathing and control symptoms of asthma and chronic obstructive pulmonary disease (COPD).

Use Combihale FF 250 Redicaps as advised by the doctor. Your doctor will decide the dose and duration based on your medical condition. The common side effects of Combihale FF 250 Redicaps include nausea, vomiting, respiratory tract infection, headache, sore throat, cough, bone, muscle or joint pain, increased heart rate, chills, tiredness and noisy breathing. Most of these side effects of Combihale FF 250 Redicaps do not require medical attention and typically resolve on their own over time. However, if the side effects are persistent, reach out to your doctor.

Do not use Combihale FF 250 Redicaps to treat sudden, severe asthma symptoms or as a rescue inhaler. Please check with your doctor if you are pregnant, currently breastfeeding or taking any other prescribed or non-prescribed medicines. If you experience severe difficulty in breathing, please consult a doctor immediately so that alternative medicine may be prescribed. Regular monitoring of potassium levels is recommended while taking Combihale FF 250 Redicaps as it may cause low potassium levels in the blood. Limited information is available regarding the usage of Combihale FF 250 Redicaps in children, so please consult a doctor if you have any concerns.

Combihale FF 250 Redicaps is used to manage and prevent respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). The detailed uses of Combihale FF 250 Redicaps are as follows:

• Controls and prevents asthma symptoms like wheezing, shortness of breath, and chest tightness.
• Improves lung function, reduces flare-ups, and eases symptoms such as cough and difficulty breathing in COPD patients.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Place the mouthpiece between your lips, press the inhaler, and breathe in slowly. Hold your breath for up to 10 seconds, then breathe out slowly. Repeat until you have inhaled the number of puffs as advised by your doctor.
• Rinse your mouth with water and spit it out after using Combihale FF 250 Redicaps to avoid fungal infections in the mouth and throat. Check the label for directions and use as advised by the doctor.

Combihale FF 250 Redicaps provides effective relief and management of respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD). Its combination of Formoterol fumarate and Fluticasone propionate offers dual benefits: Formoterol relaxes airway muscles to improve airflow and ease breathing, while Fluticasone reduces airway inflammation to prevent swelling and irritation. This helps reduce symptoms such as shortness of breath, wheezing, and coughing, improves lung function, and lowers the risk of asthma and COPD exacerbations, leading to better overall respiratory health and quality of life.

Do not stop taking this medicine on your own unless advised by your doctor. Before taking Combihale FF 250 Redicaps , let your doctor know if you have a history of heart, liver, kidney diseases, high blood pressure, hypokalaemia (low potassium levels in the blood), aneurysm (swelling of an artery), pheochromocytoma (adrenal gland tumour), hyperadrenocorticism (high levels of cortisol), eye disorders like cataract and glaucoma, chickenpox or measles, immune system problem, seizure (fits), osteoporosis (weak and brittle bones) and diabetes. Combihale FF 250 Redicaps may cause hypokalemia (low potassium levels in the blood). Therefore, they should be used with caution in patients with hypokalaemia to prevent any cardiovascular effects. Special precautions should be taken in patients with a fungal, bacterial, parasitic, or viral infection, as well as those with tuberculosis, since nasal or inhaled corticosteroids, such as Fluticasone propionate, can cause secondary infections. Combihale FF 250 Redicaps can cause a rise in blood glucose levels. Hence, monitor your blood glucose levels regularly and inform your doctor if you already have diabetes before using Combihale FF 250 Redicaps . Please let your doctor know if you are pregnant or breastfeeding.